Want high dividend yields? If you're looking for high-yield investments, you might want to consider the sector that accounts for nearly one-fifth of the nation's economy. I'm talking about healthcare, of course.
Three healthcare stocks in particular boast high dividend yields and good overall prospects. Here's why AbbVie (NYSE:ABBV), Pfizer (NYSE:PFE), and Novo Nordisk (NYSE:NVO) are high-yield healthcare investments you can buy right now.
Source: Motley Fool
Related Articles:
- 7 Dividend Stocks Delivering The Secret To Success
- 5 Low-Risk, High-Yielding Dividend Stocks
- 9 Dividend Stocks For A Rainy Day
- 6 Dividend Growth Stocks With Strong Capital Appreciation
- 6 Higher Yielding Basic Materials Stocks With Growing Dividends
________________________________________________________________
Subscribe to:
Post Comments (Atom)
Popular Posts Last 30 Days
-
These days, the healthcare stocks are looking pretty healthy compared to stocks in other spaces. Despite political pressures about lowering ...
-
These three dividend aristocrats have beaten the market during the three most recent pullbacks. They've also outperformed in 2019. There...
-
Nothing makes life easier for an investor than finding the kind of stocks where you can park money for a long, long time, trusting that they...
-
As the sun sinks on another summer and Labor Day taunts with the pitiful proposition of just 24 hours less work, it stands to reason that so...
-
In Five High-Dividend Stocks You Should Watch, we discussed five dividend stocks, including MLPs, trading at yields above 11%. In this artic...
-
The past decade has rewarded investors with remarkable returns, but investors might not want to underestimate the odds that an economic rece...
-
This company recently released solid second quarter earnings. The mortgage REIT once again outearned its dividend with core earnings in Q2-2...
-
Conservative investors should adopt the same precautions toward monthly dividend stocks as you would any income-generating investment. For i...
-
This company released Q2-2019 results recently. The results beat both revenue and earnings estimates. It reported decreasing earnings on the...
-
As a risk-averse income investor, I always approach double-digit yielders with caution. The reason is simple: when most blue-chip companies ...
0 comments
Post a Comment
Post a Comment
Note: Only a member of this blog may post a comment.